IA
VNDA icon

IndexIQ Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

IndexIQ Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-28,116
Closed -$441K – 1530
2021
Q4 		$441K Sell
28,116
-1,817
-6% -$31.7K 0.01% 691
2021
Q3 		$513K Buy
29,933
+2,998
+11% +$52.5K 0.02% 534
2021
Q2 		$579K Sell
26,935
-38
-0.1% -$680 0.02% 401
2021
Q1 		$405K Buy
26,973
+6,756
+33% +$109K 0.01% 589
2020
Q4 		$266K Buy
20,217
+2,088
+12% +$25.1K 0.01% 761
2020
Q3 		$175K Buy
18,129
+984
+6% +$10.5K 0.01% 754
2020
Q2 		$196K Sell
17,145
-2,201
-11% -$24.9K 0.01% 600
2020
Q1 		$200K Buy
+19,346
New +$240K 0.01% 304

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

IndexIQ Advisors's VNDA Position: Q1 2022 in Review

IndexIQ Advisors sold out of Vanda Pharmaceuticals (VNDA) in Q1 2022, closing a stake of 28,116 shares — an estimated $441K sold.

IndexIQ Advisors first reported a position in VNDA in Q1 2020 and held it in 8 quarters. The position peaked at $579K in Q2 2021. 188 funds tracked by Wall St. Rank hold VNDA as of Q1 2022.

  • IndexIQ Advisors reported no remaining Vanda Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • IndexIQ Advisors sold 28,116 Vanda Pharmaceuticals shares in Q1 2022, an estimated $441K.
  • IndexIQ Advisors first reported a position in Vanda Pharmaceuticals in Q1 2020 and held it in 8 quarters.
  • IndexIQ Advisors's Vanda Pharmaceuticals position peaked at $579K in Q2 2021.
  • 188 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.